ARCHIVES

FDA Continues Bureaucratic Delays Of Cancer INDs

This article is from The Cancer Letter archive.

Vol. 02 No. 05 | January 30, 1976

Download PDF Visit The Full Archive

Related Articles

Cancer Prevention Fellowship Program Offers Enhancement

March 8, 1991

DCCP Board Okays New, Recompeting Contracts Worth $4.6 Million In ‘81

October 17, 1980

Anidulafungin Safe And Well-Tolerated In Pediatric Patients With Neutropenia

November 26, 2004

In Brief: House Appropriations Committee Gives NCI $725 Million, Smallest Increase Since 1970

June 1, 1975

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

NCCS Networker Volume 5 Issue 2, Spring 1991

April 13, 1991